Journal article 185 views
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok,
Vanna Chiarion-Sileni,
Piotr Rutkowski,
C. Lance Cowey,
Dirk Schadendorf
,
John Wagstaff,
Paola Queirolo,
Reinhard Dummer,
Marcus O. Butler,
Andrew G. Hill,
Michael A. Postow
,
Caroline Gaudy-Marqueste,
Theresa Medina,
Christopher D. Lao,
John Walker,
Iván Márquez-Rodas,
John B.A.G. Haanen,
Massimo Guidoboni,
Michele Maio,
Patrick Schöffski,
Matteo S. Carlino,
Shahneen Sandhu,
Céleste Lebbé,
Paolo A. Ascierto
,
Georgina V. Long
,
Corey Ritchings,
Ayman Nassar,
Margarita Askelson,
Melanie Pe Benito,
Wenjia Wang,
F. Stephen Hodi,
James Larkin
New England Journal of Medicine, Volume: 392, Issue: 1, Pages: 11 - 22
Swansea University Author: John Wagstaff
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1056/nejmoa2407417
Abstract
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
| Published in: | New England Journal of Medicine |
|---|---|
| ISSN: | 0028-4793 1533-4406 |
| Published: |
Massachusetts Medical Society
2025
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa69784 |
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Issue: |
1 |
| Start Page: |
11 |
| End Page: |
22 |

